Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01521338 · ClinicalTrials.gov registry record

G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)

A clinical trial of Cystic Fibrosis, sponsored by Steven M Rowe.

Completed
Registry status
120
Enrollment target
20
Study locations

NCT01521338 is a study of Cystic Fibrosis that has completed, run by Steven M Rowe. The registered enrollment target is 120 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01521338, a study of Cystic Fibrosis, has completed, sponsored by Steven M Rowe.

COMPLETED
Registry status
120 participants
Enrollment target
20
Study locations

Study Summary

The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future research.We will also use some of the collected blood to measure the number of neutrophils.

Conditions Studied

Cystic Fibrosis

Study Locations (20)

Michigan

  • University of Michigan - Ann Arbor
  • Children's Hospital of Michigan - Detroit
  • Grand Rapids CF Center - Grand Rapids

Colorado

  • The Children's Hospital Colarado - Aurora
  • National Jewish Health - Denver

Indiana

  • Riley Hospital for Children Indiana University Medical Center - Indianapolis
  • Indianapolis University - Indianapolis

Massachusetts

  • Massachusetts General Hospital - Boston
  • Children's Hospital Boston - Boston

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • Phoenix Childrens Hospital - Phoenix

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

California

  • Stanford University Medical Center - Palo Alto

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2014-01
Est. Completion 2021-06

Sponsor

Steven M Rowe

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01521338

The ClinicalTrials.gov registry entry for NCT01521338 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (33% lower). The listed sponsor is Steven M Rowe, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.

NCT01521338 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Michigan, Colorado, Indiana.

Frequently Asked Questions

What is clinical trial NCT01521338 about?

NCT01521338 is a clinical study titled "G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)". The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future research.We will also use some of the collected blood to measure the number of neutrophils.

What is the current status of trial NCT01521338?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-01. Estimated completion is 2021-06.

What conditions does trial NCT01521338 study?

This clinical trial studies the following conditions: Cystic Fibrosis.

Who is sponsoring clinical trial NCT01521338?

This trial is sponsored by Steven M Rowe, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01521338 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cystic Fibrosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.